These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10604014)

  • 1. ["Buffalo hump" related to indinavir treatment].
    Dornier C; Posth M; Granel F; Barbaud A; Schmutz JL
    Ann Dermatol Venereol; 1999 Oct; 126(10):720-2. PubMed ID: 10604014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ["Buffalo neck": an unintended secondary effect of treatment with anti-HIV protease inhibitors].
    Milpied-Homsi B; Krempf M; Gueglio B; Raffi F; Stalder JF
    Ann Dermatol Venereol; 1999 Mar; 126(3):254-6. PubMed ID: 10394440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lipodystrophy and 'buffalo hump' during treatment with HIV protease inhibitors].
    Dieleman JP; Hillebrand-Haverkort ME; van der Ende ME; Sturkenboom MC; Lange JM; Stricker BH
    Ned Tijdschr Geneeskd; 1998 Dec; 142(52):2856-60. PubMed ID: 10065260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous side effects induced by indinavir.
    Calista D; Boschini A
    Eur J Dermatol; 2000 Jun; 10(4):292-6. PubMed ID: 10846257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Metabolic complications associated with use of protease inhibitors].
    Mosnier-Pudar H
    Ann Med Interne (Paris); 2000 Jun; 151(4):278-82. PubMed ID: 10922955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV protease inhibitor-related lipodystrophy syndrome.
    Carr A
    Clin Infect Dis; 2000 Jun; 30 Suppl 2():S135-42. PubMed ID: 10860898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protease problems.
    Price J
    STEP Perspect; 1998; 98(3):3-5. PubMed ID: 11365827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential gene expression indicates that 'buffalo hump' is a distinct adipose tissue disturbance in HIV-1-associated lipodystrophy.
    Guallar JP; Gallego-Escuredo JM; Domingo JC; Alegre M; Fontdevila J; Martínez E; Hammond EL; Domingo P; Giralt M; Villarroya F
    AIDS; 2008 Mar; 22(5):575-84. PubMed ID: 18316998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in body shape and metabolic abnormalities.
    Res Initiat Treat Action; 1999 Jan; 5(1):18. PubMed ID: 11366225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased incidence of indinavir nephrolithiasis in patients with hepatitis B or C virus infection.
    Malavaud B; Dinh B; Bonnet E; Izopet J; Payen JL; Marchou B
    Antivir Ther; 2000 Mar; 5(1):3-5. PubMed ID: 10846585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disorders of lipid metabolism in patients with HIV disease treated with antiretroviral agents: frequency, relationship with administered drugs, and role of hypolipidaemic therapy with bezafibrate.
    Manfredi R; Chiodo F
    J Infect; 2001 Apr; 42(3):181-8. PubMed ID: 11545549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Buffalo hump in HIV patients: surgical management with liposuction.
    Sharma D; Bitterly TJ
    J Plast Reconstr Aesthet Surg; 2009 Jul; 62(7):946-9. PubMed ID: 18468504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic problems and PIs.
    Treat Rev; 1997 Nov; (No 26-27):13. PubMed ID: 11364932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of discontinuing stavudine or protease inhibitor therapy on human immunodeficiency virus-related fat redistribution evaluated by dual-energy x-ray absorptiometry.
    Tavassoli N; Bagheri H; Sommet A; Delpierre C; Marion-Latard F; Massip P; Aquilina C; Bonnet E; Obadia M; Labau E; Montastruc JL; Bernard J
    Pharmacotherapy; 2006 Feb; 26(2):154-61. PubMed ID: 16466321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protease inhibitor-induced lipodystrophy.
    Williamson K; Reboli AC; Manders SM
    J Am Acad Dermatol; 1999 Apr; 40(4):635-6. PubMed ID: 10188689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lipodystrophy: a complication of protease inhibitors in HIV seropositive patients].
    Hermieu JF; Leport C; Ravery V; Delmas V; Boccon-Gibod L
    Prog Urol; 1999 Jun; 9(3):537-40. PubMed ID: 10434332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crixivan side effect update - hair loss and ingrown toenails.
    Fornataro K; Jefferys R
    Body Posit; 1999 Oct; 12(10):12. PubMed ID: 11366875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Images in clinical medicine. Lipodystrophy associated with an HIV-protease inhibitor.
    Carr A; Cooper DA
    N Engl J Med; 1998 Oct; 339(18):1296. PubMed ID: 9791146
    [No Abstract]   [Full Text] [Related]  

  • 19. Urolithiasis associated with the protease inhibitor indinavir.
    Bruce RG; Munch LC; Hoven AD; Jerauld RS; Greenburg R; Porter WH; Rutter PW
    Urology; 1997 Oct; 50(4):513-8. PubMed ID: 9338724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipodystrophy in HIV-infected pediatric patients receiving protease inhibitors.
    Temple ME; Koranyi KI; Nahata MC
    Ann Pharmacother; 2003 Sep; 37(9):1214-8. PubMed ID: 12921501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.